AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGRX

<< 이전 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2017/08/19	04:04	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/05	02:23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/04	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/04	05:23	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/03	21:24	GlobeNewswire Inc.	Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/03	06:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/03	05:56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/08/03	05:05	GlobeNewswire Inc.	Agile Therapeutics Announces Proposed Offering of Common Stock	NASDAQ:AGRX	Agile Therapeutics Inc
2017/07/29	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/07/28	20:35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/07/28	20:30	GlobeNewswire Inc.	Agile Therapeutics Reports Second Quarter 2017 Financial Results	NASDAQ:AGRX	Agile Therapeutics Inc
2017/07/28	19:05	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/07/28	05:12	GlobeNewswire Inc.	Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/27	21:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/27	21:00	GlobeNewswire Inc.	Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/15	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/10	06:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/06/09	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/12	21:00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/12	20:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/10	06:02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/09	05:24	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/09	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/09	05:11	GlobeNewswire Inc.	Agile Therapeutics Reports First Quarter 2017 Financial Results	NASDAQ:AGRX	Agile Therapeutics Inc
2017/05/07	03:05	GlobeNewswire Inc.	Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017	NASDAQ:AGRX	Agile Therapeutics Inc